Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9540318
APP PUB NO 20150361039A1
SERIAL NO

14819836

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXO GROUP LIMITEDBRENTFORD MIDDLESEX

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Birault, Véronique Stevenage, GB 2 7
Campbell, Amanda Jennifer Stevenage, GB 8 43
Harrison, Stephen Stevenage, GB 111 3089
Le, Joelle Stevenage, GB 45 655

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 10, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00